研究文章
血清细胞因子水平及其与自身免疫性肝病患者的临床特征
表4
斯皮尔曼秩实验室变量之间的相关性和血清细胞因子水平测量。鉴于数字
值。统计上显著的相关性是标有斜体字体。
|
|
总胆红素 |
ESR |
AST |
AlkP |
白蛋白 |
γ球蛋白 |
|
| AILD |
| - 2 |
−0.28 (0.034) |
0.03 (0.84) |
−0.17 (0.21) |
−0.16 (0.27) |
0.07 (0.67) |
0.09 (0.57) |
| il - 4 |
−0.04 (0.75) |
0.16 (0.25) |
−0.04 (0.80) |
0.07 (0.65) |
0.14 (0.37) |
−0.04 (0.80) |
| il - 6 |
0.23 (0.08) |
0.10 (0.46) |
0.02 (0.88) |
−0.12 (0.43) |
−0.30 (0.044) |
0.25 (0.10) |
| 引发 |
0.42 (0.001) |
0.41 (0.002) |
0.32 (0.018) |
0.45 (0.001) |
−0.33 (0.026) |
0.18 (0.23) |
| 肿瘤坏死因子-α |
0.18 (0.17) |
−0.07 (0.59) |
0.11 (0.44) |
0.12 (0.40) |
−0.13 (0.41) |
0.08 (0.61) |
|
| AIH |
| - 2 |
−0.25 (0.18) |
−0.13 (0.50) |
−0.37 (0.052) |
−0.18 (0.39) |
0.13 (0.53) |
−0.06 (0.79) |
| il - 4 |
−0.21 (0.27) |
−0.14 (0.47) |
−0.14 (0.48) |
−0.45 (0.023) |
0.26 (0.20) |
−0.07 (0.72) |
| il - 6 |
0.24 (0.20) |
0.02 (0.90) |
0.20 (0.30) |
0.22 (0.29) |
−0.29 (0.15) |
0.02 (0.92) |
| 引发 |
0.43 (0.017) |
0.32 (0.09) |
0.40 (0.032) |
0.37 (0.07) |
−0.32 (0.11) |
0.20 (0.32) |
| 肿瘤坏死因子-α |
−0.09 (0.63) |
−0.36 (0.05) |
0.05 (0.79) |
0.03 (0.90) |
−0.14 (0.50) |
0.15 (0.47) |
|
| 重叠综合征 |
| - 2 |
−0.33 (0.08) |
0.38 (0.07) |
−0.03 (0.87) |
−0.19 (0.38) |
0.05 (0.86) |
0.11 (0.65) |
| il - 4 |
0.21 (0.28) |
0.31 (0.14) |
−0.07 (0.74) |
−0.01 (0.97) |
−0.12 (0.62) |
0.20 (0.41) |
| il - 6 |
0.27 (0.16) |
0.49 (0.014) |
−0.09 (0.67) |
−0.20 (0.36) |
−0.39 (0.10) |
0.46 (0.046) |
| 引发 |
0.34 (0.08) |
0.27 (0.19) |
0.09 (0.66) |
0.19 (0.37) |
−0.41 (0.08) |
0.25 (0.31) |
| 肿瘤坏死因子-α |
0.56 (0.002) |
0.28 (0.17) |
0.22 (0.27) |
0.21 (0.32) |
−0.12 (0.62) |
0.09 (0.90) |
|
|
AILD:自身免疫性肝病;AIH:自身免疫性肝炎;IL:白介素;肿瘤坏死因子-α:肿瘤坏死因子α;ESR:红细胞沉降率;AST:天冬氨酸转氨酶;AlkP:碱性磷酸酶。
|
